Gross Profit for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current gross profit (TTM) is $4.92B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$4.92B
YoY change
+9.7%
5Y CAGR
+7.6%
Peak year (2025)
$4.74B
Cumulative gross profit
$50.29B
Gross Profit history chart for Edwards Lifesciences (EW) from 1999 to 2025
Gross Profit history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $4.74B | +9.7% | ||
| 2024 | $4.32B | +8.8% | ||
| 2023 | $3.97B | -5.8% | ||
| 2022 | $4.22B | +5.2% | ||
| 2021 | $4.01B | +21.9% | ||
| 2020 | $3.29B | +3.0% | ||
| 2019 | $3.19B | +14.0% | ||
| 2018 | $2.80B | +9.7% | ||
| 2017 | $2.55B | +18.3% | ||
| 2016 | $2.16B | +19.3% | ||
| 2015 | $1.81B | +7.0% | ||
| 2014 | $1.69B | +12.7% | ||
| 2013 | $1.50B | +7.8% | ||
| 2012 | $1.39B | +14.4% | ||
| 2011 | $1.22B | +17.4% | ||
| 2010 | $1.04B | +13.0% | ||
| 2009 | $917.30M | +10.7% | ||
| 2008 | $828.80M | +16.8% | ||
| 2007 | $709.80M | +8.6% | ||
| 2006 | $653.70M | +4.9% | ||
| 2005 | $623.30M | +11.0% | ||
| 2004 | $561.30M | +12.0% | ||
| 2003 | $501.10M | +23.8% | ||
| 2002 | $404.90M | +10.0% | ||
| 2001 | $368.00M | -3.4% | ||
| 2000 | $381.00M | -13.2% | ||
| 1999 | $439.00M | — |
Gross Profit values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Edwards Lifesciences (EW) most recent annual gross profit stands at $4.74B (2025) – grew 9.7% year-over-year.
Across 2020–2025 (5 years), Edwards Lifesciences gross profit produced a CAGR of +7.6% – sustaining 2 straight years of year-over-year growth.
$4.74B stands as the all-time-high annual gross profit, posted in 2025, against a low of $368.00M during 2001.
Edwards Lifesciences (EW) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
Edwards Lifesciences Gross Profit by Year
Edwards Lifesciences Gross Profit 2025: $4.74B
Edwards Lifesciences gross profit in 2025 was $4.74B, grew 9.7% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Gross Profit 2024: $4.32B
Edwards Lifesciences gross profit in 2024 was $4.32B, grew 8.8% from 2023.
Edwards Lifesciences Gross Profit 2023: $3.97B
Edwards Lifesciences gross profit in 2023 was $3.97B, declined 5.8% below 2022.
Edwards Lifesciences Gross Profit 2022: $4.22B
Edwards Lifesciences gross profit in 2022 was $4.22B, grew 5.2% from 2021.
Edwards Lifesciences Gross Profit 2021: $4.01B
Edwards Lifesciences gross profit in 2021 was $4.01B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Gross Profit
Companies in the same sector as Edwards Lifesciences, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's gross profit?
- Latest reported gross profit for Edwards Lifesciences (EW) is $4.92B (period ending March 31, 2026).
How has Edwards Lifesciences gross profit changed year-over-year?
- Edwards Lifesciences (EW) gross profit changed +9.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences gross profit?
- Edwards Lifesciences (EW) gross profit compound annual growth rate is +7.6% over the most recent 5 years available.
When did Edwards Lifesciences gross profit hit its highest annual value?
- Edwards Lifesciences gross profit reached its highest annual value of $4.74B in 2025.
What was Edwards Lifesciences gross profit in 2024?
- Edwards Lifesciences (EW) gross profit in 2024 was $4.32B.
What was Edwards Lifesciences gross profit in 2025?
- Edwards Lifesciences (EW) gross profit in 2025 was $4.74B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.